Skip to content
10-Q

Quarterly Report

ENDO HEALTH SOLUTIONS INC.

0001100962-13-000044

← back to feed
Filed
Nov 5, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Oct 31, 2013 114.89M sh
Shares Diluted Q3 2013 · Sep 30, 2013 120.26M sh
Shares Diluted Q3 2013 · Sep 30, 2013 116.89M sh
Shares Diluted Q3 2013 · Sep 30, 2012 119.58M sh
Shares Diluted Q3 2013 · Sep 30, 2012 116.69M sh
Stock Repurchased Q3 2013 · Sep 30, 2013 $0
Stock Repurchased Q3 2013 · Sep 30, 2012 $156M
Capex Q3 2013 · Sep 30, 2013 $54.35M
Capex Q3 2013 · Sep 30, 2012 $90.13M
Operating Cash Flow Q3 2013 · Sep 30, 2013 $272.47M
Operating Cash Flow Q3 2013 · Sep 30, 2012 $297.13M
Long Term Debt Q3 2013 · Sep 30, 2013 $2.64B
Long Term Debt Q3 2013 · Dec 31, 2012 $3.04B
Short Term Debt Q3 2013 · Sep 30, 2013 $411.69M
Short Term Debt Q3 2013 · Dec 31, 2012 $134M
Cash And Equivalents Q3 2013 · Sep 30, 2013 $594.09M
Cash And Equivalents Q3 2013 · Dec 31, 2012 $547.92M
Cash And Equivalents Q3 2013 · Sep 30, 2012 $256.92M
Cash And Equivalents Q3 2013 · Mar 31, 2012 $256.92M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $547.62M
Stockholders Equity Q3 2013 · Sep 30, 2013 $1.28B
Stockholders Equity Q3 2013 · Dec 31, 2012 $1.07B
Current Liabilities Q3 2013 · Sep 30, 2013 $1.68B
Current Liabilities Q3 2013 · Dec 31, 2012 $1.73B
Total Liabilities Q3 2013 · Sep 30, 2013 $2.66B
Total Liabilities Q3 2013 · Dec 31, 2012 $3.06B
Current Assets Q3 2013 · Sep 30, 2013 $2.04B
Current Assets Q3 2013 · Dec 31, 2012 $1.97B
Total Assets Q3 2013 · Sep 30, 2013 $6.46B
Total Assets Q3 2013 · Dec 31, 2012 $6.57B
Eps Diluted Q3 2013 · Sep 30, 2013 $0.33
Eps Diluted Q3 2013 · Sep 30, 2013 $0.77
Eps Diluted Q3 2013 · Sep 30, 2012 $0.45
Eps Diluted Q3 2013 · Sep 30, 2012 −$0.21
Eps Basic Q3 2013 · Sep 30, 2013 $0.35
Eps Basic Q3 2013 · Sep 30, 2013 $0.80
Eps Basic Q3 2013 · Sep 30, 2012 $0.46
Eps Basic Q3 2013 · Sep 30, 2012 −$0.21
Sga Expense Q3 2013 · Sep 30, 2013 $199.72M
Sga Expense Q3 2013 · Sep 30, 2013 $689.44M
Sga Expense Q3 2013 · Sep 30, 2012 $210.45M
Sga Expense Q3 2013 · Sep 30, 2012 $698.52M
Rd Expense Q3 2013 · Sep 30, 2013 $38.08M
Rd Expense Q3 2013 · Sep 30, 2013 $113.74M
Rd Expense Q3 2013 · Sep 30, 2012 $48.95M
Rd Expense Q3 2013 · Sep 30, 2012 $183.07M
Net Income Q3 2013 · Sep 30, 2013 $40.22M
Net Income Q3 2013 · Sep 30, 2013 $90.57M
Net Income Q3 2013 · Sep 30, 2012 $53.81M
Net Income Q3 2013 · Sep 30, 2012 −$24.07M
Operating Income Q3 2013 · Sep 30, 2013 $117.28M
Operating Income Q3 2013 · Sep 30, 2013 $291.49M
Operating Income Q3 2013 · Sep 30, 2012 $143.52M
Operating Income Q3 2013 · Sep 30, 2012 $152.59M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $287.97M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $883.06M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $294.27M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $953.66M
Revenue Q3 2013 · Sep 30, 2013 $714.95M
Revenue Q3 2013 · Sep 30, 2013 $2.19B
Revenue Q3 2013 · Sep 30, 2012 $750.48M
Revenue Q3 2013 · Sep 30, 2012 $2.23B